HCA finished 2023 with 124 ASCs and 24 endoscopy centers, which saw 1,044,415 total surgery cases — a 2.1% increase year over year. Outpatient procedures accounted for 38.3% of patient revenues, and the health system does not expect its growth to stop there; it expects to earn between $5.2 billion and $5.6 billion this year.
The health system has made a splash in the ASC space just one month into the year.
Surgery Ventures, HCA’s ASC operator business, acquired a majority interest in two Texas ASCs. They will now be a part of HCA-affiliated Medical City Healthcare: Anna-based Medical City Surgery Center of North Texas, formerly known as Surgery Center of North Texas, and Medical City Surgery Center Allen (Texas), formerly Allen Surgery Center.
HCA also proposed a new ASC in Hanover, Va., which would involve relocating existing operating rooms at two of its facilities in Richmond, Va.-based Retreat Doctors’ Hospital and Henrico (Va.) Doctors’ Hospital. Pending approval, the new ASC is expected to cost $20.8 million.
Despite HCA being the fourth-largest outpatient surgery center operator nationwide, competition in the ASC sector this year is expected to be fierce; in a recent survey of healthcare executives by Avanza Healthcare Strategies, 71% said their systems are planning to increase ASC investments and partnerships.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
